Differentiation of secondary and tertiary tricyclic antidepressants in frogs
Oksenkrug, G.F.; Lapin, I.P.
Biulleten' Eksperimental'noi Biologii i Meditsiny 73(7): 64-66
1972
ISSN/ISBN: 0365-9615 PMID: 4537998 Document Number: 45036
Document emailed within 1 workday
Related Documents
Dolgo-Saburov, V.B.; Oksenkrug, G.F. 1974: Effect of tertiary and secondary tricyclic antidepressants on the (K+--Na+)-adenosine triphosphatase activity of rabbit liver mitochondria Farmakologiia i Toksikologiia 37(6): 698-699Spiker, D.G. 1978: The toxicity of tricyclic antidepressants Communications in Psychopharmacology 2(5): 419-427
Jackson, W.K.; Roose, S.P.; Glassman, A.H. 1987: Cardiovascular toxicity and tricyclic antidepressants Biomedicine and PharmacoTherapy 41(7): 377-382
Chodorowski, Z.; Anand, J.S. 1999: Suicidal poisoning with tricyclic antidepressants Przeglad Lekarski 56(6): 438-441
1993: Tricyclic antidepressants: advantages and limitations Geriatrics 48 Suppl. 2: 6-8
Gwynne, J.F. 1971: Tricyclic antidepressants and heart disease New Zealand Medical Journal 74(475): 414-415
Small, G.W. 1989: Tricyclic antidepressants for medically ill geriatric patients Journal of Clinical Psychiatry 50 Suppl: 27-31; Discussion: 32-33
Braithwaite, R.A. 1980: Plasma-protein binding of tricyclic antidepressants Postgraduate Medical Journal 56(Suppl 1): 107-111
Judd, F.; Boyce, P. 1999: Tricyclic antidepressants in the treatment of depression. do they still have a place? Australian Family Physician 28(8): 809-813
Brunswick, D.J.; Mendels, J. 1977: Reduced levels of tricyclic antidepressants in plasma from Vacutainers Communications in Psychopharmacology 1(2): 131-134
Syrek, M.; Wójcikowski, J.; Daniel, W.A. 1997: Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants Polish Journal of Pharmacology 49(6): 453-462
Sundaram, K.; Mahajan, S. 1980: Theoretical studies on tricyclic antidepressants. I. Molecular structures Physiological Chemistry and Physics 12(4): 323-336
2003: Older tricyclic antidepressants were potent suicide-agents Lakartidningen 100(18): 1651-1652
Preskorn, S.H. 1994: Therapeutic drug monitoring with tricyclic antidepressants: a response Journal of Clinical Psychopharmacology 14(4): 277-278
Márquez del Cid, J.; Vergara Chozas, J.M.; Crespo, S.; Meca Rovayo, M.L. 1991: The efficacy of hemoperfusion in acute poisoning by tricyclic antidepressants Medicina Clinica 97(14): 555
Glassman, A.H.; Walsh, B.T.; Roose, S.P.; Rosenfeld, R.; Bruno, R.L.; Bigger, J.T.; Giardina, E.G. 1982: Factors related to orthostatic hypotension associated with tricyclic antidepressants Journal of Clinical Psychiatry 43(5 Part 2): 35-38
Des Lauriers, A.; Widlocher, D.; Allilaire, J.F.; Lecrubier, Y.; Simon, P. 1980: Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine Annales de Medecine Interne 131(8): 508-509
Detaevernier, M.R.; Dryon, L.; Massart, D.L. 1976: The separation of some tricyclic antidepressants by high-performance liquid chromatography Journal of Chromatography 128(1): 204-207
Biamino, G.; Fenner, H.; Schüren, K.P.; Neye, J.; Ramdohr, B.; Lohmann, R.W. 1975: Cardiovascular side effects of tricyclic antidepressants - a risk in the use of these drugs International Journal of Clinical Pharmacology and Biopharmacy 11(3): 253-261
Zácková, P.; Kunová, A.; Benetková, M. 1989: Different cardiovascular effects of tricyclic antidepressants in the conscious and anesthetized rats Activitas Nervosa Superior 31(1): 31-32